...
首页> 外文期刊>Pharmaceutical research >Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats.
【24h】

Mechanism-based pharmacokinetic-pharmacodynamic modeling of the dopamine D2 receptor occupancy of olanzapine in rats.

机译:奥氮平在大鼠中多巴胺D2受体占有率的基于机理的药代动力学-药效学建模。

获取原文
获取原文并翻译 | 示例

摘要

PURPOSE: A mechanism-based PK-PD model was developed to predict the time course of dopamine D(2) receptor occupancy (D(2)RO) in rat striatum following administration of olanzapine, an atypical antipsychotic drug. METHODS: A population approach was utilized to quantify both the pharmacokinetics and pharmacodynamics of olanzapine in rats using the exposure (plasma and brain concentration) and D(2)RO profile obtained experimentally at various doses (0.01-40 mg/kg) administered by different routes. A two-compartment pharmacokinetic model was used to describe the plasma pharmacokinetic profile. A hybrid physiology- and mechanism-based model was developed to characterize the D(2) receptor binding in the striatum and was fitted sequentially to the data. The parameters were estimated using nonlinear mixed-effects modeling . RESULTS: Plasma, brain concentration profiles and time course of D(2)RO were well described by the model; validity of the proposed model is supported by good agreement between estimated association and dissociation rate constants and in vitro values from literature. CONCLUSION: This model includes both receptor binding kinetics and pharmacokinetics as the basis for the prediction of the D(2)RO in rats. Moreover, this modeling framework can be applied to scale the in vitro and preclinical information to clinical receptor occupancy.
机译:目的:建立了一种基于机制的PK-PD模型,以预测非典型抗精神病药物奥氮平给药后大鼠纹状体中多巴胺D(2)受体的占有时间(D(2)RO)的时间过程。方法:采用人口方法,通过不同剂量(0.01-40 mg / kg)不同剂量实验获得的暴露(血浆和脑部浓度)和D(2)RO图谱,定量测定奥氮平在大鼠体内的药代动力学和药效学。路线。使用两室药代动力学模型来描述血浆药代动力学特征。混合生理和基于机制的模型被开发来表征纹状体中的D(2)受体结合,并顺序地拟合到数据。使用非线性混合效应模型估算参数。结果:该模型很好地描述了D(2)RO的血浆,脑部浓度分布和时间过程。估计的缔合和解离速率常数与文献中的体外值之间的良好一致性支持了所提出模型的有效性。结论:该模型包括受体结合动力学和药代动力学,作为预测大鼠D(2)RO的基础。此外,该建模框架可用于将体外和临床前信息扩展到临床受体的使用情况。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号